Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms.
Thyroid hormone receptors (TRs) play critical roles in energy homeostasis. To understand the role of TRs in lipid homeostasis in vivo, we adopted the loss-of-function approach by creating knock-in mutant mice with targeted mutation in the TRalpha gene (TRalpha1PV mouse) or TRbeta gene (TRbetaPV mouse). The PV mutation, identified in a patient with resistance to thyroid hormone, exhibits potent dominant-negative activity. Here we show that in contrast to TRalpha1PV mouse, TRbetaPV mice exhibited no significant reduction in WAT but had significant increases in serum free fatty acids and total triglycerides. Moreover, the liver of TRbetaPV mice was markedly increased (33%) with excess lipid accumulation, but the liver mass of TRalpha1PV mouse was decreased (23%) with paucity of lipids. These results indicate that apo-TRbeta and apo-TRalpha1 exerted distinct abnormalities in lipid metabolism. Further biochemical analyses indicate that increased lipogenic enzyme expression, activated peroxisome proliferator-activated receptor gamma (Ppargamma) signaling, and decreased fatty acid beta-oxidation activity contributed to the adipogenic steatosis and lipid accumulation in the liver of TRbetaPV mice. In contrast, the expression of lipogenic enzymes and Ppargamma was decreased in the liver of TRalpha1PV mice. These results suggest that the regulation of genes critical for lipid metabolism by TRs in the liver is isoform dependent. These results indicate that apo-TRbeta and apo-TRalpha1 had different effects on lipid metabolism and that both TR isoforms contribute to the pathogenesis of lipid metabolism in hypothyroidism.
Araki
O
O
Laboratory of Molecular Biology, National Cancer Institute, 37 Convent Drive, Room 5128, Bethesda, Maryland 20892-4264, USA.
Ying
H
H
Zhu
X G
XG
Willingham
M C
MC
Cheng
S Y
SY
D050156:Adipogenesis / Q000235:genetics; D052436:Adipose Tissue, White / Q000378:metabolism / Q000473:pathology; D000818:Animals; D005234:Fatty Liver / Q000209:etiology / Q000473:pathology; D006529:Hepatomegaly / Q000209:etiology / Q000473:pathology; D007037:Hypothyroidism / Q000150:complications / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D008024:Ligands; D050356:Lipid Metabolism / Q000187:drug effects / Q000235:genetics*; D050155:Lipogenesis / Q000235:genetics; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D010084:Oxidation-Reduction; D020033:Protein Isoforms / Q000819:agonists / Q000235:genetics / Q000502:physiology; D011988:Receptors, Thyroid Hormone / Q000819:agonists / Q000235:genetics / Q000502:physiology*; D013963:Thyroid Hormones / Q000494:pharmacology; D015533:Transcriptional Activation
D008024:Ligands; D020033:Protein Isoforms; D011988:Receptors, Thyroid Hormone; D013963:Thyroid Hormones